Cargando…

The Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease

The immune system is activated in Parkinson's Disease (PD), as evidenced by neuroinflammatory changes within the brain as well as elevated immune markers in peripheral blood. Furthermore, inflammatory cytokine levels in the blood are associated with disease severity and rate of progression. How...

Descripción completa

Detalles Bibliográficos
Autores principales:	White, Alice J., Wijeyekoon, Ruwani S., Scott, Kirsten M., Gunawardana, Nushan P., Hayat, Shaista, Solim, I. H., McMahon, H. T., Barker, Roger A., Williams-Gray, Caroline H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256248/ https://www.ncbi.nlm.nih.gov/pubmed/30524354 http://dx.doi.org/10.3389/fneur.2018.00946

Ejemplares similares

Monocyte Function in Parkinson's Disease and the Impact of Autologous Serum on Phagocytosis
por: Wijeyekoon, Ruwani S., et al.
Publicado: (2018)

A Systematic Review and Meta-Analysis of Alpha Synuclein Auto-Antibodies in Parkinson's Disease
por: Scott, Kirsten M., et al.
Publicado: (2018)

Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
por: Menon, Sindhu, et al.
Publicado: (2022)

Dermal Phospho-Alpha-Synuclein Deposition in Patients With Parkinson's Disease and Mutation of the Glucocerebrosidase Gene
por: Doppler, Kathrin, et al.
Publicado: (2018)

B lymphocyte responses in Parkinson’s disease and their possible significance in disease progression
por: Scott, Kirsten M, et al.
Publicado: (2023)

Cerebrospinal Fluid Cytokines and Neurodegeneration‐Associated Proteins in Parkinson's Disease
por: Wijeyekoon, Ruwani S., et al.
Publicado: (2020)

Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease
por: Chang, Chun-Wei, et al.
Publicado: (2020)

Erythrocytic alpha-synuclein as potential biomarker for the differentiation between essential tremor and Parkinson’s disease
por: Yu, Zhenwei, et al.
Publicado: (2023)

Longitudinal Alterations of Alpha-Synuclein, Amyloid Beta, Total, and Phosphorylated Tau in Cerebrospinal Fluid and Correlations Between Their Changes in Parkinson's Disease
por: Dolatshahi, Mahsa, et al.
Publicado: (2018)

The Current Status of Neural Grafting in the Treatment of Huntington’s Disease. A Review
por: Wijeyekoon, Ruwani, et al.
Publicado: (2011)

Cathepsin Oxidation Alters Alpha-Synuclein Processing
por: Ferree, Andrew W.
Publicado: (2019)

Abnormalities of age-related T cell senescence in Parkinson’s disease
por: Williams-Gray, C. H., et al.
Publicado: (2018)

Increased Intestinal Permeability Correlates with Sigmoid Mucosa alpha-Synuclein Staining and Endotoxin Exposure Markers in Early Parkinson's Disease
por: Forsyth, Christopher B., et al.
Publicado: (2011)

Transcriptome and Proteome Analysis in LUHMES Cells Overexpressing Alpha-Synuclein
por: Höllerhage, Matthias, et al.
Publicado: (2022)

A Meta-Analysis of α-Synuclein Multiplication in Familial Parkinsonism
por: Book, Adam, et al.
Publicado: (2018)

Validity of CSF alpha-synuclein to predict psychosis in prodromal Alzheimer's disease
por: Monge-García, Sonia, et al.
Publicado: (2023)

Neuroprotective Role of Quercetin against Alpha-Synuclein-Associated Hallmarks in Parkinson’s Disease
por: Das, Sabya Sachi, et al.
Publicado: (2023)

Editorial: Targeting α-Synuclein in Parkinson's Disease and Multiple System Atrophy
por: Fellner, Lisa, et al.
Publicado: (2022)

Optimization of the Detection Method for Phosphorylated α-Synuclein in Parkinson Disease by Skin Biopsy
por: Liu, Xiaojing, et al.
Publicado: (2020)

Targeting α-Synuclein in Parkinson's Disease by Induced Pluripotent Stem Cell Models
por: Spathopoulou, Angeliki, et al.
Publicado: (2022)

Transmission of alpha-synuclein in Parkinson’s disease
por: Lee, Virginia M-Y
Publicado: (2013)

Alpha-synuclein spreading in Parkinson’s disease
por: Recasens, Ariadna, et al.
Publicado: (2014)

Alpha-Synuclein Aggregation in Parkinson's Disease
por: Srinivasan, E., et al.
Publicado: (2021)

Differential Diagnosis of Multiple System Atrophy-Parkinsonism and Parkinson's Disease Using α-Synuclein and External Anal Sphincter Electromyography
por: Cao, Zhentang, et al.
Publicado: (2020)

Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
por: Gómez-Benito, Mónica, et al.
Publicado: (2020)

Alpha-Synuclein and Cognitive Decline in Parkinson Disease
por: Fan, Tian-Sin, et al.
Publicado: (2021)

Exposure of α-Synuclein Aggregates to Organotypic Slice Cultures Recapitulates Key Molecular Features of Parkinson's Disease
por: Moudio, Serge, et al.
Publicado: (2022)

Somatic Alpha-Synuclein Mutations in Parkinson's Disease: Hypothesis and Preliminary Data
por: Proukakis, Christos, et al.
Publicado: (2013)

Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE‐PD)
por: Williams‐Gray, Caroline H., et al.
Publicado: (2016)

Senescence and Inflammatory Markers for Predicting Clinical Progression in Parkinson’s Disease: The ICICLE-PD Study
por: Martin-Ruiz, Carmen, et al.
Publicado: (2020)

Peptide-based approaches to directly target alpha-synuclein in Parkinson’s disease
por: Allen, Scott G., et al.
Publicado: (2023)

Diagnostic utility of CSF α-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysis
por: Eusebi, Paolo, et al.
Publicado: (2016)

Rationale for Therapeutic Silencing of Alpha-Synuclein in Parkinson’s Disease
por: Maraganore, Demetrius M.
Publicado: (2011)

Interaction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease
por: Xu, Shengli, et al.
Publicado: (2015)

Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation
por: George, Sonia, et al.
Publicado: (2015)

New Perspectives on Roles of Alpha-Synuclein in Parkinson’s Disease
por: Zhang, Guoxin, et al.
Publicado: (2018)

The Identification of Alpha-Synuclein as the First Parkinson Disease Gene
por: Nussbaum, Robert L.
Publicado: (2017)

Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson’s Disease
por: Fitzgerald, Emily, et al.
Publicado: (2019)

Targeting Alpha-Synuclein as a Therapy for Parkinson’s Disease
por: Fields, Carroll Rutherford, et al.
Publicado: (2019)

Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease
por: Li, Puyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8tb4u4bvi6pa792nd4vf8dkarh